CalciMedica is trading at $1.29, up 7.10% in pre-market, with no clear company-specific catalyst identified.

  • The latest company press-release listing shows no release dated October 13.
  • A September 30 filing allowed sales of up to $25 million in stock, but does not establish a cause for this morning’s move.
  • Major indexes were mixed; none moved more than 0.5% in the same direction as the stock.